Allstate (WBO:ALLS) YoY EBITDA Growth: 52.77% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:ALLS Allstate Corp WBO:ALLS
67 GF Score
Price €231.50
GF Value €193.52
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Allstate YoY EBITDA Growth?

Allstate WBO:ALLS -1.87% 67 YoY EBITDA Growth is 52.77% as of Jun. 2026. GuruFocus rates WBO:ALLS with a GF Score™ of 67/100 and a GF Value™ of €193.52 (Modestly Overvalued). The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Allstate's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 52.77%.

Allstate's EBITDA per Share for the three months ended in Jun. 2026 was €14.49.

Allstate YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Allstate's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allstate YoY EBITDA Growth Chart

Allstate Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.67 -109.67 213.83 832.63 87.39

Allstate Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 312.98 188.17 72.10 232.81 52.77
WBO:ALLS
67GF Score
Allstate Corp WBO:ALLS
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allstate YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Allstate's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(44.881-23.95)/ | 23.95 |
=87.39 %

Allstate's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(14.486-9.482)/ | 9.482 |
=52.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 52.77% mean?
Allstate (WBO:ALLS) has a YoY EBITDA Growth of 52.77% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Allstate and its competitors.
Is Allstate's YoY EBITDA Growth too high?
Allstate's current YoY EBITDA Growth is 52.77%. Overall, Allstate has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Allstate's YoY EBITDA Growth compare to TRV and CINF?
Allstate's YoY EBITDA Growth of 52.77% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Insurance company?
A good YoY EBITDA Growth depends on the Insurance industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Allstate and its competitors. Allstate's current YoY EBITDA Growth is 52.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allstate stock overvalued right now?
Based on GuruFocus' analysis, Allstate (WBO:ALLS) is currently considered Modestly Overvalued. The stock's GF Value™ is €193.52, compared to a current price of €231.50 — trading 19.6% above its estimated fair value. The current YoY EBITDA Growth is 52.77%. Allstate's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Allstate (WBO:ALLS), the current YoY EBITDA Growth is 52.77% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allstate (WBO:ALLS) Overvalued in 2026?

Based on GuruFocus' analysis, Allstate stock appears to be overvalued. The current stock price of €231.50 is trading 19.6% above its estimated GF Value™ of €193.52. GuruFocus considers Allstate to be Modestly Overvalued.

Key valuation signals for WBO:ALLS:

  • YoY EBITDA Growth: 52.77%
  • GF Value™: €193.52 vs. price of €231.50 (19.6% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the WBO:ALLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allstate Business Description

Address 3100 Sanders Road, Northbrook, IL, USA, 60062
Allstate is one of the largest US property-casualty insurers in the US. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 6,000 exclusive agents.
67GF Score

Get the complete analysis for WBO:ALLS

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€231.50
Price
€193.52
GF Value